Top Markets
Coin of the day
Immunovia AB Immunovia AB

Immunovia AB

IMMNOV
Rank in Stocks #34134
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Share Price
$0.018005
Last synced: 2026-08-14
Market Cap
$6.17M
Change (1 day)
-1.71%
Change (1 year)
-60.12%
Country
SE
Trade Immunovia AB (IMMNOV)

Category

Price of IMMNOV with the market cap of B
Immunovia AB Immunovia AB
IMMNOV
$0.018005
Market Capitalization of Immunovia AB(IMMNOV)
Market Cap: $6.17M
As of August 2026 Immunovia AB has a market cap of $6.17M. This makes Immunovia AB the world's 34134th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Immunovia AB from 2015 to 2026
IMMNOV compared with Top 5 Most Popular stocks
Price of IMMNOV Asset B Mkt. of B Results
Immunovia AB Immunovia AB
$15,917.26 $6.17M
$5.452T +88,404,594.51%
Immunovia AB Immunovia AB
$13,109.05 $6.17M
$4.490T +72,807,767.10%
Immunovia AB Immunovia AB
$12,152.56 $6.17M
$4.162T +67,495,360.07%
Immunovia AB Immunovia AB
$10,733.44 $6.17M
$3.676T +59,613,585.83%
Immunovia AB Immunovia AB
$8,271.35 $6.17M
$2.833T +45,939,068.02%